Kristen Hege is a director of Adaptimmune Therapeutics Plc.
Person profile
Roles
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Adaptimmune Therapeutics PLC
17 Jan 24
4
Mersana Therapeutics, Inc.
4 Jan 24
3
Adaptimmune Therapeutics PLC
1 Nov 23
4
Mersana Therapeutics, Inc.
4 Oct 23
4
Graphite Bio, Inc.
21 Jul 23
4
Mersana Therapeutics, Inc.
6 Jul 23
4
Mersana Therapeutics, Inc.
12 Jun 23
4
Mersana Therapeutics, Inc.
5 Apr 23
4
Graphite Bio, Inc.
22 Jun 22
4
Mersana Therapeutics, Inc.
10 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.14 | 81,906 | 11.47 k | 81,906 |
2 Jan 24 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.27 | 6,447 | 14.63 k | 6,447 |
2 Oct 23 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 9,523 | 12.00 k | 9,523 |
19 Jul 23 | LENZ LENZ Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.72 | 20,000 | 54.40 k | 20,000 |